IBDEI1F5 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22949,1,3,0)
;;=3^S/P Non-Melanoma Skin Cancer
;;^UTILITY(U,$J,358.3,22949,1,4,0)
;;=4^Z85.828
;;^UTILITY(U,$J,358.3,22949,2)
;;=^5063443
;;^UTILITY(U,$J,358.3,22950,0)
;;=Z85.820^^76^992^2
;;^UTILITY(U,$J,358.3,22950,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22950,1,3,0)
;;=3^S/P Melanoma
;;^UTILITY(U,$J,358.3,22950,1,4,0)
;;=4^Z85.820
;;^UTILITY(U,$J,358.3,22950,2)
;;=^5063441
;;^UTILITY(U,$J,358.3,22951,0)
;;=L57.8^^76^992^3
;;^UTILITY(U,$J,358.3,22951,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22951,1,3,0)
;;=3^Actinic Damage
;;^UTILITY(U,$J,358.3,22951,1,4,0)
;;=4^L57.8
;;^UTILITY(U,$J,358.3,22951,2)
;;=^5009226
;;^UTILITY(U,$J,358.3,22952,0)
;;=L57.0^^76^992^4
;;^UTILITY(U,$J,358.3,22952,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22952,1,3,0)
;;=3^Actinic Keratosis
;;^UTILITY(U,$J,358.3,22952,1,4,0)
;;=4^L57.0
;;^UTILITY(U,$J,358.3,22952,2)
;;=^66900
;;^UTILITY(U,$J,358.3,22953,0)
;;=D48.5^^76^992^5
;;^UTILITY(U,$J,358.3,22953,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22953,1,3,0)
;;=3^Neoplasm of Uncertain Behavior
;;^UTILITY(U,$J,358.3,22953,1,4,0)
;;=4^D48.5
;;^UTILITY(U,$J,358.3,22953,2)
;;=^267777
;;^UTILITY(U,$J,358.3,22954,0)
;;=L82.1^^76^992^6
;;^UTILITY(U,$J,358.3,22954,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22954,1,3,0)
;;=3^Seborrheic Keratosis
;;^UTILITY(U,$J,358.3,22954,1,4,0)
;;=4^L82.1
;;^UTILITY(U,$J,358.3,22954,2)
;;=^303312
;;^UTILITY(U,$J,358.3,22955,0)
;;=L82.0^^76^992^7
;;^UTILITY(U,$J,358.3,22955,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22955,1,3,0)
;;=3^Inflamed Seborrheic Keratosis
;;^UTILITY(U,$J,358.3,22955,1,4,0)
;;=4^L82.0
;;^UTILITY(U,$J,358.3,22955,2)
;;=^303311
;;^UTILITY(U,$J,358.3,22956,0)
;;=B07.9^^76^992^8
;;^UTILITY(U,$J,358.3,22956,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22956,1,3,0)
;;=3^Viral Wart
;;^UTILITY(U,$J,358.3,22956,1,4,0)
;;=4^B07.9
;;^UTILITY(U,$J,358.3,22956,2)
;;=^5000519
;;^UTILITY(U,$J,358.3,22957,0)
;;=D22.9^^76^992^9
;;^UTILITY(U,$J,358.3,22957,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22957,1,3,0)
;;=3^Mole/Melanocytic
;;^UTILITY(U,$J,358.3,22957,1,4,0)
;;=4^D22.9
;;^UTILITY(U,$J,358.3,22957,2)
;;=^5002058
;;^UTILITY(U,$J,358.3,22958,0)
;;=D23.9^^76^992^10
;;^UTILITY(U,$J,358.3,22958,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22958,1,3,0)
;;=3^Benign Neoplasm
;;^UTILITY(U,$J,358.3,22958,1,4,0)
;;=4^D23.9
;;^UTILITY(U,$J,358.3,22958,2)
;;=^5002076
;;^UTILITY(U,$J,358.3,22959,0)
;;=D18.01^^76^992^11
;;^UTILITY(U,$J,358.3,22959,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22959,1,3,0)
;;=3^Angioma
;;^UTILITY(U,$J,358.3,22959,1,4,0)
;;=4^D18.01
;;^UTILITY(U,$J,358.3,22959,2)
;;=^267697
;;^UTILITY(U,$J,358.3,22960,0)
;;=L24.89^^76^992^12
;;^UTILITY(U,$J,358.3,22960,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22960,1,3,0)
;;=3^Irritant Dermatitis
;;^UTILITY(U,$J,358.3,22960,1,4,0)
;;=4^L24.89
;;^UTILITY(U,$J,358.3,22960,2)
;;=^5009135
;;^UTILITY(U,$J,358.3,22961,0)
;;=L21.8^^76^992^13
;;^UTILITY(U,$J,358.3,22961,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22961,1,3,0)
;;=3^Seborrheic Dermatitis
;;^UTILITY(U,$J,358.3,22961,1,4,0)
;;=4^L21.8
;;^UTILITY(U,$J,358.3,22961,2)
;;=^303310
;;^UTILITY(U,$J,358.3,22962,0)
;;=L20.89^^76^992^14
;;^UTILITY(U,$J,358.3,22962,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1F5 3753 printed Sep 23, 2025@19:43:31 Page 2
IBDEI1F5 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22949,1,3,0)
+2 ;;=3^S/P Non-Melanoma Skin Cancer
+3 ;;^UTILITY(U,$J,358.3,22949,1,4,0)
+4 ;;=4^Z85.828
+5 ;;^UTILITY(U,$J,358.3,22949,2)
+6 ;;=^5063443
+7 ;;^UTILITY(U,$J,358.3,22950,0)
+8 ;;=Z85.820^^76^992^2
+9 ;;^UTILITY(U,$J,358.3,22950,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,22950,1,3,0)
+12 ;;=3^S/P Melanoma
+13 ;;^UTILITY(U,$J,358.3,22950,1,4,0)
+14 ;;=4^Z85.820
+15 ;;^UTILITY(U,$J,358.3,22950,2)
+16 ;;=^5063441
+17 ;;^UTILITY(U,$J,358.3,22951,0)
+18 ;;=L57.8^^76^992^3
+19 ;;^UTILITY(U,$J,358.3,22951,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,22951,1,3,0)
+22 ;;=3^Actinic Damage
+23 ;;^UTILITY(U,$J,358.3,22951,1,4,0)
+24 ;;=4^L57.8
+25 ;;^UTILITY(U,$J,358.3,22951,2)
+26 ;;=^5009226
+27 ;;^UTILITY(U,$J,358.3,22952,0)
+28 ;;=L57.0^^76^992^4
+29 ;;^UTILITY(U,$J,358.3,22952,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,22952,1,3,0)
+32 ;;=3^Actinic Keratosis
+33 ;;^UTILITY(U,$J,358.3,22952,1,4,0)
+34 ;;=4^L57.0
+35 ;;^UTILITY(U,$J,358.3,22952,2)
+36 ;;=^66900
+37 ;;^UTILITY(U,$J,358.3,22953,0)
+38 ;;=D48.5^^76^992^5
+39 ;;^UTILITY(U,$J,358.3,22953,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,22953,1,3,0)
+42 ;;=3^Neoplasm of Uncertain Behavior
+43 ;;^UTILITY(U,$J,358.3,22953,1,4,0)
+44 ;;=4^D48.5
+45 ;;^UTILITY(U,$J,358.3,22953,2)
+46 ;;=^267777
+47 ;;^UTILITY(U,$J,358.3,22954,0)
+48 ;;=L82.1^^76^992^6
+49 ;;^UTILITY(U,$J,358.3,22954,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,22954,1,3,0)
+52 ;;=3^Seborrheic Keratosis
+53 ;;^UTILITY(U,$J,358.3,22954,1,4,0)
+54 ;;=4^L82.1
+55 ;;^UTILITY(U,$J,358.3,22954,2)
+56 ;;=^303312
+57 ;;^UTILITY(U,$J,358.3,22955,0)
+58 ;;=L82.0^^76^992^7
+59 ;;^UTILITY(U,$J,358.3,22955,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,22955,1,3,0)
+62 ;;=3^Inflamed Seborrheic Keratosis
+63 ;;^UTILITY(U,$J,358.3,22955,1,4,0)
+64 ;;=4^L82.0
+65 ;;^UTILITY(U,$J,358.3,22955,2)
+66 ;;=^303311
+67 ;;^UTILITY(U,$J,358.3,22956,0)
+68 ;;=B07.9^^76^992^8
+69 ;;^UTILITY(U,$J,358.3,22956,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,22956,1,3,0)
+72 ;;=3^Viral Wart
+73 ;;^UTILITY(U,$J,358.3,22956,1,4,0)
+74 ;;=4^B07.9
+75 ;;^UTILITY(U,$J,358.3,22956,2)
+76 ;;=^5000519
+77 ;;^UTILITY(U,$J,358.3,22957,0)
+78 ;;=D22.9^^76^992^9
+79 ;;^UTILITY(U,$J,358.3,22957,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,22957,1,3,0)
+82 ;;=3^Mole/Melanocytic
+83 ;;^UTILITY(U,$J,358.3,22957,1,4,0)
+84 ;;=4^D22.9
+85 ;;^UTILITY(U,$J,358.3,22957,2)
+86 ;;=^5002058
+87 ;;^UTILITY(U,$J,358.3,22958,0)
+88 ;;=D23.9^^76^992^10
+89 ;;^UTILITY(U,$J,358.3,22958,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,22958,1,3,0)
+92 ;;=3^Benign Neoplasm
+93 ;;^UTILITY(U,$J,358.3,22958,1,4,0)
+94 ;;=4^D23.9
+95 ;;^UTILITY(U,$J,358.3,22958,2)
+96 ;;=^5002076
+97 ;;^UTILITY(U,$J,358.3,22959,0)
+98 ;;=D18.01^^76^992^11
+99 ;;^UTILITY(U,$J,358.3,22959,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,22959,1,3,0)
+102 ;;=3^Angioma
+103 ;;^UTILITY(U,$J,358.3,22959,1,4,0)
+104 ;;=4^D18.01
+105 ;;^UTILITY(U,$J,358.3,22959,2)
+106 ;;=^267697
+107 ;;^UTILITY(U,$J,358.3,22960,0)
+108 ;;=L24.89^^76^992^12
+109 ;;^UTILITY(U,$J,358.3,22960,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,22960,1,3,0)
+112 ;;=3^Irritant Dermatitis
+113 ;;^UTILITY(U,$J,358.3,22960,1,4,0)
+114 ;;=4^L24.89
+115 ;;^UTILITY(U,$J,358.3,22960,2)
+116 ;;=^5009135
+117 ;;^UTILITY(U,$J,358.3,22961,0)
+118 ;;=L21.8^^76^992^13
+119 ;;^UTILITY(U,$J,358.3,22961,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,22961,1,3,0)
+122 ;;=3^Seborrheic Dermatitis
+123 ;;^UTILITY(U,$J,358.3,22961,1,4,0)
+124 ;;=4^L21.8
+125 ;;^UTILITY(U,$J,358.3,22961,2)
+126 ;;=^303310
+127 ;;^UTILITY(U,$J,358.3,22962,0)
+128 ;;=L20.89^^76^992^14
+129 ;;^UTILITY(U,$J,358.3,22962,1,0)
+130 ;;=^358.31IA^4^2
